BFC Bank First Corporation - Fundamental Analysis
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Ref P/E, PEG, Graham Number
- Forward P/E of 12.92 below sector average of 22.39
- Price below analyst target of $151.00
- Current price ($137.32) above Graham Number ($101.58)
- High P/E of 19.13 and P/S of 9.13 suggest premium valuation
Ref Growth rates
- YoY EPS growth of 14.9% and revenue growth of 6.80%
- Forward P/E contraction suggests earnings expectations are priced in
- Q/Q earnings growth slowing to +8.7%
- PEG Ratio unavailable limits growth-adjusted valuation
Ref Historical trends
- 5Y return of +120.4% significantly outperforms sector
- History of beating earnings estimates in recent quarters
- Earnings misses in 2023 with surprises as low as -24.1%
- Volatility in quarterly performance suggests inconsistency
Ref Altman Z-Score, Piotroski F-Score
- ROE of 11.24% exceeds sector average (which is negative)
- Operating margin strength indicates pricing power
- Piotroski F-Score of 3/9 indicates weak financial health
- Missing Altman Z-Score, Debt/Equity, and liquidity ratios
Ref Yield, Payout
- Payout ratio of 25.32% is sustainable
- Dividend strength score of 25/100 suggests room for improvement
- Yield of 1.33% is below sector average for financials
- No 5-year average yield to assess consistency
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BFC and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BFC
Bank First Corporation
Primary
|
+120.4% | +89.8% | +41.8% | +9.5% | +7.0% | +6.0% |
|
BCAT
BlackRock Capital Allocation Term Trust
Peer
|
+28.2% | +62.6% | +16.7% | +9.3% | +5.2% | +0.9% |
|
BMEZ
BlackRock Health Sciences Term Trust
Peer
|
-15.2% | +31.8% | +7.0% | +16.6% | +2.9% | +1.9% |
|
BSTZ
BlackRock Science and Technology Term Trust
Peer
|
+4.5% | +76.4% | +17.1% | +13.7% | -0.8% | -0.1% |
|
BTT
Blackrock Municipal 2030 Target Term Trust
Peer
|
+1.3% | +10.1% | +11.1% | +3.8% | +1.3% | -0.8% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Quarterly Earnings History
EPS performance vs analyst estimates
Financial Services Sector Comparison
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BFC
Bank First Corporation
|
NEUTRAL | $1.54B | 19.13 | 11.2% | 41.9% | $137.32 | |
|
BCAT
BlackRock Capital...
|
BEARISH | $1.54B | 9.72 | -% | -% | $14.67 | |
|
BMEZ
BlackRock Health Sciences...
|
BEARISH | $1.57B | - | -% | -% | $15.54 | |
|
BSTZ
BlackRock Science and...
|
BEARISH | $1.6B | 3.64 | -% | -% | $22.64 | |
|
BTT
Blackrock Municipal 2030...
|
NEUTRAL | $1.48B | 24.82 | 3.5% | 66.0% | $22.59 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-03 | LEMAHIEU KEVIN M | Chief Financial Officer | Gift | 2,000 | $257,000 |
| 2025-08-19 | STAYER-SUPRICK MICHAEL S | Director | Purchase | 410 | $50,295 |
Wall Street Analysts
Professional analyst ratings and price targets
Past News Coverage
Recent headlines mentioning BFC from our newsroom.